Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025)
Alpha Tau Medical's (DRTS) quarterly Long-Term Deferred Tax came in at $97000.0 in Q4 2025, down 97.45% quarter-over-quarter from $3.8 million in Q4 2021.
Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
Alpha Tau Medical has disclosed Long-Term Deferred Tax across 3 years of filings, most recently posting $97000.0 for Q4 2025.
- Long-Term Deferred Tax for Q4 2025 came in at $97000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $97000.0 (changed N/A YoY), and the FY2025 annual result was $97000.0, changed N/A from the prior year.
- Long-Term Deferred Tax came in at $97000.0 for Q4 2025 at Alpha Tau Medical, down from $3.8 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $3.8 million in Q4 2021 to a low of $97000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2021 | 3.80 Mn |
| Dec 31, 2020 | 2.23 Mn |